동물 진단 시장 보고서 : 제품, 기술, 동물 종류, 질병 종류, 최종사용자, 지역별(2025-2033년)

The global veterinary diagnostics market size reached USD 7.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 13.0 Billion by 2033, exhibiting a growth rate (CAGR) of 6.97% during 2025-2033. North America dominates the market owing to its well-established veterinary infrastructure, rising adoption of state-of-the-art diagnostic technologies, and an increasing emphasis on animal health management. The growing number of pet ownerships, increasing demand for preventive care of pets, and rising awareness about zoonotic diseases, which can be transmitted between animals and humans, are some of the major factors propelling the market.

The growing acknowledgment of the significance of animal health is resulting in heightened focus on prompt diagnosis and disease prevention. Pet parents, livestock farmers, and veterinary specialists are increasingly prioritizing early detection and regular check-ups to ensure health, lower treatment expenses, and enhance animal longevity and productivity. Moreover, initiatives by both the government and industry to enhance veterinary health systems are encouraging the adoption of diagnostics. Policies that promote disease surveillance, compulsory testing, and biosecurity strengthen the importance of diagnostics in safeguarding public health and animal welfare, catalyzing the demand in both private and institutional veterinary care environments. Apart from this, ongoing advancements in diagnostic techniques, such as automation, molecular tools, and data analysis, are greatly enhancing the efficiency, precision, and dependability of veterinary testing. These advancements allow for more accurate disease detection, streamlined processes, and increased accessibility of tests, positioning diagnostics as a key element of contemporary veterinary care and administration.

Veterinary Diagnostics Market Trends:

Demand for Fast and Accurate Testing

Veterinary practitioners are increasingly depending on diagnostic tools that provide swift and precise results to aid prompt clinical decision-making. In rapidly advancing cases, delays in receiving test results can jeopardize treatment efficacy and animal recuperation. The need for quick diagnostic results is leading to the creation and use of technologies that deliver instant information at the point of care or via expedited lab processing. High-precision instruments guarantee accurate evaluations, decreasing the chances of incorrect diagnoses and superfluous procedures. This focus on promptness and precision boosts clinical productivity, increases client trust, and fosters improved patient results. With ongoing time-sensitive situations in practices, the demand for diagnostics that can provide quick and reliable information is growing within different veterinary care environments. In 2024, Zoetis announced the global launch of its new AI-powered hematology analyzer, Vetscan OptiCell(TM), debuting at VMX in Orlando from January 25-29, 2025. The screenless, cartridge-based device combined viscoelastic focusing and AI to deliver rapid, accurate CBC results.

Increase in Veterinary Education and Clinical Training

The development of veterinary education and the focus on clinical training are facilitating the incorporation of diagnostics into routine veterinary practice. Veterinary colleges and training centers currently prioritize practical experience with diagnostic tools, lab analysis, and evidence-based treatment planning. This exposure influences the expectations and clinical behaviors of novice professionals, who begin their practice with a solid grounding in diagnostic procedures. As a result, diagnostics are considered essential rather than optional tools for clinical assessment and decision-making. The rising availability of continuing education programs also ensures that established practitioners stay informed about emerging technologies and diagnostic methods. This culture of continuous learning enhances the importance of diagnostics in the profession and encourages the embrace of innovative solutions. The educational system, by consistently emphasizing the importance of proper testing, fosters a more diagnostics-focused veterinary workforce.

Technological Innovation and Diagnostic Advancements

Ongoing advancements in fields like clinical biochemistry, molecular testing, and digital imaging are enhancing the accuracy, rapidity, and range of diagnostic abilities. These advancements are improving the dependability and precision of test outcomes, allowing veterinarians to make better-informed clinical choices. Additionally, integration with digital platforms facilitates efficient data handling, quick analysis of results, and improved monitoring of animal health over time. Moreover, automation and enhanced usability are making diagnostic tools more available to veterinary practitioners, aiding in efficient practice management and elevated service quality. With the ongoing advancements in technology, the field of veterinary diagnostics is becoming increasingly complex, allowing for earlier interventions and tailored care. In line with this trend, in 2024, Center Point Bio-Tech launched its advanced veterinary diagnostic system, AlphaION, at VMX 2024 in Orlando, surpassing order expectations. AlphaION combined AI, automation, and innovations like surface acoustic wave (SAW) testing to expand in-clinic diagnostic capabilities. It enabled faster, more accurate, and cost-effective diagnostics for various animal species.

Veterinary Diagnostics Market Growth Drivers:

Expanding Animal Health Investments and Infrastructure

The public and private sectors are investing more resources to enhance veterinary infrastructure, advance disease control initiatives, and boost diagnostic capabilities. This is evident in the evolution of contemporary laboratories, improved education for veterinary practitioners, and the broad access to sophisticated testing equipment. For example, in 2024, the West Bengal Livestock Development Corporation launched a new pet diagnostic service at its CLART facility in Kalyani. Pet parents in Kolkata and nearby suburbs could book home sample collections online, with testing conducted at the government lab. The initiative included free testing at static collection points in Salt Lake and Barasat. A robust infrastructure enables increased diagnostic capacity, enhanced service delivery, and reliable quality assurance. With the growing recognition of the wider effects of animal health, particularly regarding public health, food safety, and economic viability, diagnostics are emerging as a key focus.

Rising Need for Early Detection of Complex Conditions

With the growing awareness about chronic and possibly life-threatening conditions in animals, veterinarians and pet parents are pursuing diagnostic options that can detect irregularities prior to the onset of serious clinical symptoms. Sophisticated testing instruments allow professionals to assess organ functionality, recognize cellular modifications, and pinpoint indicators that facilitate prompt, focused interventions. This move towards prompt diagnosis enhances treatment results, reduces invasive procedures, and improves the quality of life for animals. The shift towards proactive and precision-oriented veterinary care highlights the significance of diagnostics in clinical processes, promoting continued use of both routine and specialized testing services in various practice types. In 2024, Antech, part of Mars Science & Diagnostics, announced two new veterinary innovations in North America, including AIS RapidRead and the Nu.Q(R) Canine Cancer Test. AIS RapidRead used AI to deliver near-instant radiology insights, while Nu.Q(R) offered rapid cancer screening for dogs. Both tools aimed to improve diagnostic speed, accuracy, and care outcomes.

Growing Focus on Livestock Health Management

With the rising demand for premium animal-based food products, producers are progressively utilizing diagnostic solutions to mitigate disease risk, improve reproductive efficiency, and maintain regulatory compliance. Routine health evaluations via diagnostics aid in preserving biosecurity, minimizing financial losses from diseases, and promoting sustainable agricultural methods. This is resulting in the incorporation of diagnostics into herd health initiatives, especially in commercial farming practices. Enhanced monitoring and prompt disease detection lead to improved preparation and decreased dependence on urgent care options. The capability to assess general herd health, monitor performance metrics, and identify subclinical issues is emerging as a useful resource for producers. As the global livestock sector faces pressure to satisfy food supply demands without jeopardizing animal welfare, the importance of diagnostics as a preventive and management resource is becoming more vital.

Veterinary Diagnostics Industry Segmentation:

Breakup by Product:

• Instruments
• Kits and Reagents
• Software and Services

Kits and reagents dominate the market

Kits and reagents play a crucial role in veterinary diagnostics and provide essential tools and substances for conducting various diagnostic tests. They include pre-packaged reagents and instructions for conducting tests, such as enzyme-linked immunosorbent assays (ELISAs) or polymerase chain reaction (PCR) assays. The reagents in these kits are designed to detect specific pathogens or disease markers, allowing veterinarians to diagnose infectious diseases spontaneously and accurately in animals. They are also used to measure parameters, such as complete blood counts, blood chemistries (including liver and kidney function), electrolyte levels, and blood clotting abilities. They assist in detecting abnormalities, such as the presence of bacteria, parasites, blood, or abnormal levels of certain chemicals or metabolites.

Breakup by Technology:

• Immunodiagnostics
• Clinical Biochemistry
• Molecular Diagnostics
• Hematology
• Others

Clinical biochemistry holds the largest share in the market

Clinical biochemistry is a fundamental component of veterinary diagnostics that involves the analysis of blood and other body fluids to assess the physiological and biochemical status of animals. It provides valuable information about organ function, metabolic processes, and the presence of diseases or abnormalities. It helps measure a wide range of parameters, including enzymes, electrolytes, proteins, metabolites, hormones, and waste products. It encompasses various tests, which are conducted using specialized laboratory equipment and reagents. It also focuses on providing quantitative data that helps veterinarians in the diagnosis, monitoring, and treatment of various conditions. Furthermore, by evaluating the levels of specific analytes in the blood, such as liver enzymes, kidney function markers (creatinine), glucose, albumin, and electrolytes (sodium and potassium), clinical biochemistry aids in the detection of organ dysfunction, nutritional imbalances, endocrine disorders, and metabolic abnormalities in animals.

Breakup by Animal Type:

• Companion Animals
  • Dogs
  • Cats
  • Others
• Livestock Animals
  • Cattle
  • Swine
  • Poultry
  • Others

Livestock animals hold the maximum share of the market

Livestock animals, such as cattle, pigs, sheep, and poultry, require veterinary diagnostics as it helps identify and diagnose diseases effectively. Early detection is crucial for implementing appropriate control measures to restrict the spread of infectious diseases within herds or flocks. Besides this, diagnostic tests enable veterinarians to accurately identify the causative agents, determine the extent of disease prevalence, and guide the implementation of effective treatment and preventive strategies. Veterinary diagnostic testing also helps assess the health and productivity of individual animals and the overall herd or flock. By monitoring various parameters, such as blood chemistry, fecal quality, and growth rates, veterinarians can identify and address health issues that may affect production efficiency, including nutritional deficiencies, parasitic infections, metabolic disorders, and respiratory diseases.

Breakup by Disease Type:

• Infectious Diseases
• Non-infectious Diseases
• Hereditary, Congenital and Acquired Diseases
• General Ailments
• Structural and Functional Diseases

Non-infectious diseases account for the majority of market share

Veterinary diagnostics play a crucial role in identifying infectious diseases in animals, as accurate and timely diagnosis is essential for appropriate treatment and control measures. It is essential for disease surveillance and monitoring in animal populations. By conducting diagnostic tests on individual animals or within herds or flocks, veterinarians can assess the prevalence, spread, and impact of infectious diseases. It also aids in identifying various zoonotic diseases in animals, helping prevent or minimize the transmission of pathogens from animals to humans. By diagnosing and managing infectious diseases in animals, veterinary diagnostics contribute to protect public health and prevent the spread of zoonotic infections.

Breakup by End User:

• Reference Laboratories
• Veterinary Hospitals and Clinics
• Others

Reference laboratories hold the largest share in the market

Reference laboratories play a vital role in veterinary diagnostics by providing specialized and advanced diagnostic services to support veterinarians, clinics, and research institutions. They are equipped with state-of-the-art technology, highly trained personnel, and expertise in a wide range of veterinary diagnostic disciplines. They offer a comprehensive number of diagnostic tests that may not be available at local veterinary clinics or laboratories. They often possess a broader test menu and the capacity to perform essential tests that require specialized equipment, techniques, or expertise. Reference laboratories can perform highly specific and sensitive tests to detect infectious agents, identify genetic disorders, diagnose complex diseases, and assess the overall health status of animals.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America exhibits a clear dominance, accounting for the largest veterinary diagnostics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the increase in veterinary specialty practices and referral centers. Besides this, the rising focus on pet health and wellness and advanced veterinary medicine is propelling the growth of the market.

Another contributing aspect is the increasing demand for preventive healthcare, early disease detection, and personalized treatment options to ensure their pets lead long and healthy lives is offering a favorable veterinary diagnostics market outlook.

Asia Pacific is estimated to expand further in this domain due to rising adoption of pets among millennials. Besides this, the increasing expansion of livestock and aquaculture industries is bolstering the growth of the market.

Competitive Landscape:

Key market players in the market are implementing various strategies and initiatives to improve their business. They are investing in research and development (R&D) activities to innovate and develop new diagnostic technologies, tests, and products. They are also focusing on improving the accuracy, efficiency, and speed of veterinary diagnostic tests, as well as expanding the range of diseases and conditions that can be diagnosed. Top companies are actively pursuing strategic partnerships and acquisitions to expand their product offerings, geographical reach, and market share. They are also providing telemedicine services to pet owners, comprising of consultation, monitoring, and remote diagnostic in certain scenarios. Leading companies are embracing artificial intelligence (AI), machine learning (ML), and molecular diagnostics to improve their product offerings and service delivery.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• BioChek B.V.
• Biomerieux SA
• Heska Corporation
• IDvet
• IDEXX Laboratories Inc.
• Neogen Corporation
• Randox Laboratories Ltd.
• Thermo Fisher Scientific Inc.
• Virbac
• Zoetis Inc.

Key Questions Answered in This Report

• 1.How big is the global veterinary diagnostics market?
• 2.What is the expected growth rate of the global veterinary diagnostics market during 2025-2033?
• 3.What are the key factors driving the global veterinary diagnostics market?
• 4.What has been the impact of COVID-19 on the global veterinary diagnostics market?
• 5.What is the breakup of the global veterinary diagnostics market based on the product?
• 6.What is the breakup of the global veterinary diagnostics market based on the technology?
• 7.What is the breakup of the global veterinary diagnostics market based on the animal type?
• 8.What is the breakup of the global veterinary diagnostics market based on the disease type?
• 9.What is the breakup of the global veterinary diagnostics market based on the end user?
• 10.What are the key regions in the global veterinary diagnostics market?
• 11.Who are the key players/companies in the global veterinary diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Veterinary Diagnostics Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Instruments
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Kits and Reagents
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Software and Services
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Technology

• 7.1 Immunodiagnostics
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Clinical Biochemistry
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Molecular Diagnostics
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Hematology
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Animal Type

• 8.1 Companion Animals
  • 8.1.1 Market Trends
  • 8.1.2 Major Types
    • 8.1.2.1 Dogs
    • 8.1.2.2 Cats
    • 8.1.2.3 Others
  • 8.1.3 Market Forecast
• 8.2 Livestock Animals
  • 8.2.1 Market Trends
  • 8.2.2 Major Types
    • 8.2.2.1 Cattle
    • 8.2.2.2 Swine
    • 8.2.2.3 Poultry
    • 8.2.2.4 Others
  • 8.2.3 Market Forecast

9 Market Breakup by Disease Type

• 9.1 Infectious Diseases
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Non-infectious Diseases
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Hereditary, Congenital and Acquired Diseases
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 General Ailments
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Structural and Functional Diseases
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast

10 Market Breakup by End User

• 10.1 Reference Laboratories
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Veterinary Hospitals and Clinics
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Others
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast

11 Market Breakup by Region

• 11.1 North America
  • 11.1.1 United States
    • 11.1.1.1 Market Trends
    • 11.1.1.2 Market Forecast
  • 11.1.2 Canada
    • 11.1.2.1 Market Trends
    • 11.1.2.2 Market Forecast
• 11.2 Asia Pacific
  • 11.2.1 China
    • 11.2.1.1 Market Trends
    • 11.2.1.2 Market Forecast
  • 11.2.2 Japan
    • 11.2.2.1 Market Trends
    • 11.2.2.2 Market Forecast
  • 11.2.3 India
    • 11.2.3.1 Market Trends
    • 11.2.3.2 Market Forecast
  • 11.2.4 South Korea
    • 11.2.4.1 Market Trends
    • 11.2.4.2 Market Forecast
  • 11.2.5 Australia
    • 11.2.5.1 Market Trends
    • 11.2.5.2 Market Forecast
  • 11.2.6 Indonesia
    • 11.2.6.1 Market Trends
    • 11.2.6.2 Market Forecast
  • 11.2.7 Others
    • 11.2.7.1 Market Trends
    • 11.2.7.2 Market Forecast
• 11.3 Europe
  • 11.3.1 Germany
    • 11.3.1.1 Market Trends
    • 11.3.1.2 Market Forecast
  • 11.3.2 France
    • 11.3.2.1 Market Trends
    • 11.3.2.2 Market Forecast
  • 11.3.3 United Kingdom
    • 11.3.3.1 Market Trends
    • 11.3.3.2 Market Forecast
  • 11.3.4 Italy
    • 11.3.4.1 Market Trends
    • 11.3.4.2 Market Forecast
  • 11.3.5 Spain
    • 11.3.5.1 Market Trends
    • 11.3.5.2 Market Forecast
  • 11.3.6 Russia
    • 11.3.6.1 Market Trends
    • 11.3.6.2 Market Forecast
  • 11.3.7 Others
    • 11.3.7.1 Market Trends
    • 11.3.7.2 Market Forecast
• 11.4 Latin America
  • 11.4.1 Brazil
    • 11.4.1.1 Market Trends
    • 11.4.1.2 Market Forecast
  • 11.4.2 Mexico
    • 11.4.2.1 Market Trends
    • 11.4.2.2 Market Forecast
  • 11.4.3 Others
    • 11.4.3.1 Market Trends
    • 11.4.3.2 Market Forecast
• 11.5 Middle East and Africa
  • 11.5.1 Market Trends
  • 11.5.2 Market Breakup by Country
  • 11.5.3 Market Forecast

12 SWOT Analysis

• 12.1 Overview
• 12.2 Strengths
• 12.3 Weaknesses
• 12.4 Opportunities
• 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

• 14.1 Overview
• 14.2 Bargaining Power of Buyers
• 14.3 Bargaining Power of Suppliers
• 14.4 Degree of Competition
• 14.5 Threat of New Entrants
• 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

• 16.1 Market Structure
• 16.2 Key Players
• 16.3 Profiles of Key Players
  • 16.3.1 BioChek B.V.
    • 16.3.1.1 Company Overview
    • 16.3.1.2 Product Portfolio
  • 16.3.2 Biomerieux SA
    • 16.3.2.1 Company Overview
    • 16.3.2.2 Product Portfolio
    • 16.3.2.3 Financials
    • 16.3.2.4 SWOT Analysis
  • 16.3.3 Heska Corporation
    • 16.3.3.1 Company Overview
    • 16.3.3.2 Product Portfolio
    • 16.3.3.3 Financials
    • 16.3.3.4 SWOT Analysis
  • 16.3.4 IDvet
    • 16.3.4.1 Company Overview
    • 16.3.4.2 Product Portfolio
  • 16.3.5 IDEXX Laboratories Inc.
    • 16.3.5.1 Company Overview
    • 16.3.5.2 Product Portfolio
    • 16.3.5.3 Financials
    • 16.3.5.4 SWOT Analysis
  • 16.3.6 Neogen Corporation
    • 16.3.6.1 Company Overview
    • 16.3.6.2 Product Portfolio
    • 16.3.6.3 Financials
    • 16.3.6.4 SWOT Analysis
  • 16.3.7 Randox Laboratories Ltd.
    • 16.3.7.1 Company Overview
    • 16.3.7.2 Product Portfolio
  • 16.3.8 Thermo Fisher Scientific Inc.
    • 16.3.8.1 Company Overview
    • 16.3.8.2 Product Portfolio
    • 16.3.8.3 Financials
    • 16.3.8.4 SWOT Analysis
  • 16.3.9 Virbac
    • 16.3.9.1 Company Overview
    • 16.3.9.2 Product Portfolio
    • 16.3.9.3 Financials
    • 16.3.9.4 SWOT Analysis
  • 16.3.10 Zoetis Inc.
    • 16.3.10.1 Company Overview
    • 16.3.10.2 Product Portfolio
    • 16.3.10.3 Financials
    • 16.3.10.4 SWOT Analysis